Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seon Yang Park

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Medical Oncology (Northwood, London, England)|April 8, 2011
Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patientsJoon Ho Moon, Sang Kyun Sohn, Shi Nae Kim, et al.
International Journal of Hematology|March 21, 2014
Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromesYundeok Kim, In-Ho Kim, Hyeong Joon Kim, et al.
Leukemia & Lymphoma|April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemiaSang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
The Korean Journal of Internal Medicine|July 11, 2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemiaYoung Hoon Park, Dae-Young Kim, Yeung-Chul Mun, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Medical Oncology (Northwood, London, England)|April 8, 2011
Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patientsJoon Ho Moon, Sang Kyun Sohn, Shi Nae Kim, et al.
International Journal of Hematology|March 21, 2014
Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromesYundeok Kim, In-Ho Kim, Hyeong Joon Kim, et al.
Leukemia & Lymphoma|April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemiaSang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
The Korean Journal of Internal Medicine|July 11, 2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemiaYoung Hoon Park, Dae-Young Kim, Yeung-Chul Mun, et al.
Pageof 2